Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Delta Air Lines, Inc. (DAL) Reports Record Net Income For Q2, But Shares Balk In Pre-Market Trading

Page 1 of 2

Delta Air Lines, Inc. (NYSE:DAL) has announced its second quarter 2015 financial results, posting adjusted earnings per share of $1.27, surpassing market expectations of $1.23. The airliner posted quarterly revenues of $10.71 billion, also beating market estimates of $10.63 billion, with growth of 0.8% year-over-year. It has been an excellent quarter in terms of net income, as the airliner announced growth of 85% year-over-year with net income of $1.48 billion for the quarter, along with diluted earnings per share of $1.83. On an annual basis, the market is expecting earnings per share of $4.43 on revenue of $40.98 billion. It is important to note that Delta Air Lines, Inc. (NYSE:DAL) posted a year-over-year drop in its first quarter 2015 revenue. According to Zacks, up to 92% of the analysts tracking the company hold a rating of ‘Buy’ for its stock. It’s also been an extremely popular stock among the smart money, with 116 of the funds tracked by Insider Monkey holding positions in the airliner as of March 31, far more than are invested in any other airline, and ranking it as the sixth-most popular stock overall.

Top 10 Things to Do Before You Die

We don’t just track the latest moves of funds. We are, in fact, more interested in their 13F filings, which we use to determine the top 15 small-cap stocks held by the funds we track. We gather and share this information based on 16 years of research, with backtests for the period between 1999 and 2012 and forward testing for the last 2.5 years. The results of our analysis show that these 15 most popular small-cap picks have a great potential to outperform the market, beating the S&P 500 Total Return Index by nearly one percentage point per month in backtests. Moreover, since the beginning of forward testing in August 2012, the strategy worked brilliantly, outperforming the market every year and returning 135%, which is more than 80 percentage points higher than the returns of the S&P 500 ETF (SPY) (see more details).

In a recent announcement from the airliner, it is planning to invest in the bankrupt Japanese airline, Skymark Airlines, to gain exposure to the international market. It will allow Delta Air Lines to compete with international players and according to its plan, the airline is aiming to acquire a 20% stake in the struggling airline. Some of the primary competitors of Delta Air Lines, Inc. (NYSE:DAL) in the international market include American Airlines Group Inc (NASDAQ:AAL) and United Continental Holdings Inc (NYSE:UAL). Both of these companies are offering their services under strategic alliances formed with Japanese airliners. Skymark Airlines’ largest creditor, Intrepid Aviation, was the one to suggest this alliance for the company, which filed for bankruptcy protection in January. Masaru Morimoto, Managing Director of Delta’s Japan business, said, “We have been looking for an opportunity to have an alliance partner in Japan.” However, there are no official remarks from the company about the partnership or percentage of stake it might acquire in the future.

While discussing the latest earnings results, Richard Anderson, Chief Executive Officer of Delta Air Lines, said, “Delta’s record results have allowed the company to invest in its employees through higher wage rates and profit sharing; improve the experience for our customers through new aircraft and innovative partnerships with global carriers; and uniquely deliver value for our shareholders by accelerating our capital returns while also paying down debt.”

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!